These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36512423)
1. Mini-dCas13X-mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy. Li G; Jin M; Li Z; Xiao Q; Lin J; Yang D; Liu Y; Wang X; Xie L; Ying W; Wang H; Zuo E; Shi L; Wang N; Chen W; Xu C; Yang H J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36512423 [TBL] [Abstract][Full Text] [Related]
2. Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model. Lin J; Jin M; Yang D; Li Z; Zhang Y; Xiao Q; Wang Y; Yu Y; Zhang X; Shao Z; Shi L; Zhang S; Chen WJ; Wang N; Wu S; Yang H; Xu C; Li G Nat Commun; 2024 Jul; 15(1):5927. PubMed ID: 39009678 [TBL] [Abstract][Full Text] [Related]
3. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy. Pickar-Oliver A; Gough V; Bohning JD; Liu S; Robinson-Hamm JN; Daniels H; Majoros WH; Devlin G; Asokan A; Gersbach CA Mol Ther; 2021 Nov; 29(11):3243-3257. PubMed ID: 34509668 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199 [TBL] [Abstract][Full Text] [Related]
5. In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers. Chen M; Shi H; Gou S; Wang X; Li L; Jin Q; Wu H; Zhang H; Li Y; Wang L; Li H; Lin J; Guo W; Jiang Z; Yang X; Xu A; Zhu Y; Zhang C; Lai L; Li X Genome Med; 2021 Apr; 13(1):57. PubMed ID: 33845891 [TBL] [Abstract][Full Text] [Related]
6. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. Hanson B; Wood MJA; Roberts TC RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516 [TBL] [Abstract][Full Text] [Related]
7. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Bengtsson NE; Hall JK; Odom GL; Phelps MP; Andrus CR; Hawkins RD; Hauschka SD; Chamberlain JR; Chamberlain JS Nat Commun; 2017 Feb; 8():14454. PubMed ID: 28195574 [TBL] [Abstract][Full Text] [Related]
8. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Zhang Y; Li H; Min YL; Sanchez-Ortiz E; Huang J; Mireault AA; Shelton JM; Kim J; Mammen PPA; Bassel-Duby R; Olson EN Sci Adv; 2020 Feb; 6(8):eaay6812. PubMed ID: 32128412 [TBL] [Abstract][Full Text] [Related]
9. Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy. Young CS; Mokhonova E; Quinonez M; Pyle AD; Spencer MJ J Neuromuscul Dis; 2017; 4(2):139-145. PubMed ID: 28505980 [TBL] [Abstract][Full Text] [Related]
10. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Long C; Amoasii L; Mireault AA; McAnally JR; Li H; Sanchez-Ortiz E; Bhattacharyya S; Shelton JM; Bassel-Duby R; Olson EN Science; 2016 Jan; 351(6271):400-3. PubMed ID: 26721683 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy. Wong TWY; Cohn RD Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172 [TBL] [Abstract][Full Text] [Related]
12. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Moretti A; Fonteyne L; Giesert F; Hoppmann P; Meier AB; Bozoglu T; Baehr A; Schneider CM; Sinnecker D; Klett K; Fröhlich T; Rahman FA; Haufe T; Sun S; Jurisch V; Kessler B; Hinkel R; Dirschinger R; Martens E; Jilek C; Graf A; Krebs S; Santamaria G; Kurome M; Zakhartchenko V; Campbell B; Voelse K; Wolf A; Ziegler T; Reichert S; Lee S; Flenkenthaler F; Dorn T; Jeremias I; Blum H; Dendorfer A; Schnieke A; Krause S; Walter MC; Klymiuk N; Laugwitz KL; Wolf E; Wurst W; Kupatt C Nat Med; 2020 Feb; 26(2):207-214. PubMed ID: 31988462 [TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 Correction of Duchenne Muscular Dystrophy in Mice by a Self-Complementary AAV Delivery System. Zhang Y; Bassel-Duby R; Olson EN Methods Mol Biol; 2023; 2587():411-425. PubMed ID: 36401041 [TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nelson CE; Wu Y; Gemberling MP; Oliver ML; Waller MA; Bohning JD; Robinson-Hamm JN; Bulaklak K; Castellanos Rivera RM; Collier JH; Asokan A; Gersbach CA Nat Med; 2019 Mar; 25(3):427-432. PubMed ID: 30778238 [TBL] [Abstract][Full Text] [Related]
15. The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy. Wasala NB; Million ED; Watkins TB; Wasala LP; Han J; Yue Y; Lu B; Chen SJ; Hakim CH; Duan D Hum Gene Ther; 2022 May; 33(9-10):518-528. PubMed ID: 35350865 [TBL] [Abstract][Full Text] [Related]
16. Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice. Xu L; Lau YS; Gao Y; Li H; Han R Mol Ther; 2019 Aug; 27(8):1407-1414. PubMed ID: 31129119 [TBL] [Abstract][Full Text] [Related]
17. Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles. Bengtsson NE; Tasfaout H; Hauschka SD; Chamberlain JS Mol Ther; 2021 Mar; 29(3):1070-1085. PubMed ID: 33160075 [TBL] [Abstract][Full Text] [Related]
18. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Nelson CE; Hakim CH; Ousterout DG; Thakore PI; Moreb EA; Castellanos Rivera RM; Madhavan S; Pan X; Ran FA; Yan WX; Asokan A; Zhang F; Duan D; Gersbach CA Science; 2016 Jan; 351(6271):403-7. PubMed ID: 26721684 [TBL] [Abstract][Full Text] [Related]
19. CRISPR technologies for the treatment of Duchenne muscular dystrophy. Choi E; Koo T Mol Ther; 2021 Nov; 29(11):3179-3191. PubMed ID: 33823301 [TBL] [Abstract][Full Text] [Related]
20. Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Amoasii L; Hildyard JCW; Li H; Sanchez-Ortiz E; Mireault A; Caballero D; Harron R; Stathopoulou TR; Massey C; Shelton JM; Bassel-Duby R; Piercy RJ; Olson EN Science; 2018 Oct; 362(6410):86-91. PubMed ID: 30166439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]